During chronic renal failure, patients develop bone mineralization abnormalities due to changes in hormone expression (i.e., PTH, FGF23 and vitamin D) that control mineral homeostasis and osteoblast/-clast function [23]. Here, FGF23 is linked to chronic kidney disease.